Neonet Securities Inc News

Loading the latest news for Neonet Securities Inc

1. 3/18/2013 6:06:00 AM NeuroVive Appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors
   published by PR Newswire Europe (inc. UK Disclose)
   NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company announces that Anna Malm Bernsten and Boel Flodgren have been elected to the Company's Board. Anna has an MSc in Chemical Engineering from the Royal Institute of Technology, Stockholm. Boel Flodgren is a Senior Professor of Business Law at the School of Economics and Management at Lund...
   
2. 3/18/2013 12:01:00 AM Sweden : NeuroVive: NeuroVive appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors
   published by Mena Report
   NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company announces that Anna Malm Bernsten and Boel Flodgren have been elected to the Company s Board. Anna is currently on the board of a number of companies including Nolato AB, CellaVision AB, Medivir AB and Fagerhult AB and she was previously on the board of Biophausia AB. She was the President of...
   
3. 3/18/2013 12:00:00 AM Sweden : NeuroVive: NeuroVive appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors
   published by TendersInfo News
   Sweden NeuroVive NeuroVive appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors TendersInfo News NeuroVive Pharmaceutical AB a leading mitochondrial medicine company announces that Anna Malm Bernsten and Boel Flodgren have been elected to the Company s Board Both have exceptional track records and leadership experience and are expected to make a significant contribution to NeuroViveAnna Malm Bernsten has more than 25 years of international marketing and sales experience in the healthcare industry She was until recently Chief Marketing Officer at GE Healthcare Life Sciences where she established a marketing leadership team developing branding and communication strategies for the company s key brands Anna also gained global sales experience as Vice President Global Sales at Aerocrine AB and developed her leadership skills as Chief Executive Officer at Carmeda AB Anna is currently on the board of a number of companies including Nolato AB CellaVision AB Medivir AB and Fagerhult AB and she was previously on the board of Biophausia AB Anna has an MSc in Chemical Engineering from the Royal Institute of Technology StockholmBoel Flodgren is a Senior Professor of Business Law at the School of Economics and Management at Lund University She brings to NeuroVive a wealth of academic knowledge in law and regulatory issues She was the President of Lund University for ten years and has been awarded honorary doctorate degrees from HANKEN The Swedish School of.